Prometheus Biosciences Inc (RXDX) Company Profile & Statistics

Prometheus Biosciences Inc
RXDX
(Nasdaq - US)
Closed
116.24
+1.77 (+1.55%)
in:usd•As of: Jan 27, 2023 15:59 UTC -5
Open
115.42
High
117.50
Low
113.11

About Prometheus Biosciences Inc

CEO

Mark C. McKenna

Headquarters

9410 carroll park drive

san diego, ca 92121, united states

Auditor

BDO USA, LLP

Employees

Share Holders

N/A

Website

www.prometheusbiosciences.com

Industry

biotechnology

Sector

health technology

Company Overview

Prometheus Biosciences Inc. is a biotechnology company. It involved in the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory bowel disease. Prometheus Biosciences Inc. is based in SAN DIEGO.

Prometheus Biosciences Inc Statistics

Valuation Measures

Market Capitalization ²	4.88B
Enterprise Value	4.83B
Enterprise Value/EBITDA (ttm)	-35.77
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	20.95
Price to Sales (ttm)	694.52
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	100.00%
Operating Margin (ttm)	-1847.71%
Profit Margin (ttm)	-2551.36%
Return on Equity (ttm)	-61.37%
Return on Invested Capital (ttm)	-58.03%
Return on Assets (ttm)	-50.27%

Income Statement

Revenue (ttm)	7.19M
Revenue Per Share (ttm)	0.17
Gross Profit (ttm)	7.19M
EBITDA (ttm)³	-134.93M
Net Income Avi to Common (ttm)	-132.91M
Diluted EPS (ttm)	-3.35

Share Statistics

Beta (5Y Monthly)	-0.46
52-Week Change	227.81%
S&P500 52-Week Change	-8.15%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	41.94M
Dividend Yield	0.00%
Float ⁴	36.46M
% Held by Insiders	13.08%
% Held by Institutions	78.31%

Balance Sheet

Total Cash (mrq)	260.25M
Total Cash Per Share (mrq)	6.20
Total Debt (mrq)	29.21M
Total Debt/Equity (mrq)	12.56%
Current Ratio (mrq)	11.19%
Quick Ratio (mrq)	11.19%
Book Value Per Share (mrq)	5.56

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.99
Free Cash Flow (ytd)	-84.47M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Prometheus Biosciences Inc

Trade With A Regulated Broker